Cargando…

SLC39A4 expression is associated with enhanced cell migration, cisplatin resistance, and poor survival in non-small cell lung cancer

The zinc transporter SLC39A4 influences epithelial cell morphology and migration in various cancers; however, its role in regulating cell invasion and chemotherapeutic resistance in human lung cancer is not yet clear. Here, integrated analysis of gene expression in non-small cell lung cancer reveale...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Dong-ming, Liu, Teng, Deng, Shi-hua, Han, Rong, Xu, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543149/ https://www.ncbi.nlm.nih.gov/pubmed/28775359 http://dx.doi.org/10.1038/s41598-017-07830-4

Ejemplares similares

Knockdown of SLC39A7 suppresses cell proliferation, migration and invasion in cervical cancer
por: Wei, Yongqing, et al.
Publicado: (2017)

SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma
por: Ma, Zuyi, et al.
Publicado: (2021)

Zip4 (Slc39a4) Expression is Activated in Hepatocellular Carcinomas and Functions to Repress Apoptosis, Enhance Cell Cycle and Increase Migration
por: Weaver, Benjamin P., et al.
Publicado: (2010)

Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells
por: Pan, Chun-Hao, et al.
Publicado: (2016)

Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells
por: Li, Zhao, et al.
Publicado: (2016)

CD39: the potential target in small cell lung cancer
por: Chen, Shanhao, et al.
Publicado: (2020)

SLC39A8/Zinc Suppresses the Progression of Clear Cell Renal Cell Carcinoma
por: Liu, Lilong, et al.
Publicado: (2021)

Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer
por: Ma, Yu-Shui, et al.
Publicado: (2021)

The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling
por: Wu, Dong-ming, et al.
Publicado: (2019)

Metformin enhances the radiosensitizing effect of cisplatin in non-small cell lung cancer cell lines with different cisplatin sensitivities
por: Riaz, Muhammad Assad, et al.
Publicado: (2019)

Involvement of SLC39A6 in gastric adenocarcinoma and correlation of the SLC39A6 polymorphism rs1050631 with clinical outcomes after resection
por: Gao, Jian, et al.
Publicado: (2019)

Emodin enhances cisplatin sensitivity in non-small cell lung cancer through Pgp downregulation
por: Peng, Shuai, et al.
Publicado: (2021)

Metal transporter Slc39a10 regulates susceptibility to inflammatory stimuli by controlling macrophage survival
por: Gao, Hong, et al.
Publicado: (2017)

Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis
por: Xu, Jie, et al.
Publicado: (2014)

Evaluation of the prognostic values of solute carrier (SLC) family 39 genes for patients with lung adenocarcinoma
por: Zhou, Heng, et al.
Publicado: (2021)

Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression
por: Zhang, Yunwen, et al.
Publicado: (2023)

In utero gene expression in the Slc39a8(neo/neo) knockdown mouse
por: Chen, Jing, et al.
Publicado: (2018)

Role of methylation-related genes CRYAB and SLC39A11 in the occurrence and development of lung adenocarcinoma
por: Wang, Shuying, et al.
Publicado: (2022)

The Effect of SLC2A3 Expression on Cisplatin Resistance of Colorectal Cancer Cells
por: Li, Yan, et al.
Publicado: (2021)

Tumor-endogenous PD-1 promotes cell proliferation and predicts poor survival in non-small cell lung cancer
por: Gan, Fanyi, et al.
Publicado: (2022)

The Zinc Transporter SLC39A10 Plays an Essential Role in Embryonic Hematopoiesis
por: He, Xuyan, et al.
Publicado: (2023)

SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma
por: Cui, Xiao-Bin, et al.
Publicado: (2015)

Role of SLC39A6 in the development and progression of liver cancer
por: Wan, Zhen, et al.
Publicado: (2022)

Clinical, molecular and glycophenotype insights in SLC39A8-CDG
por: Bonaventura, Eleonora, et al.
Publicado: (2021)

Aspirin enhances cisplatin sensitivity of resistant non-small cell lung carcinoma stem-like cells by targeting mTOR-Akt axis to repress migration
por: Khan, Poulami, et al.
Publicado: (2019)

Oxymatrine and Cisplatin Synergistically Enhance Anti-tumor Immunity of CD8(+) T Cells in Non-small Cell Lung Cancer
por: Ye, Jin, et al.
Publicado: (2018)

FIGNL1 is overexpressed in small cell lung cancer patients and enhances NCI-H446 cell resistance to cisplatin and etoposide
por: Ma, Jian, et al.
Publicado: (2017)

USP39 regulates the cell cycle, survival, and growth of human leukemia cells
por: Liu, Chunxia, et al.
Publicado: (2019)

WISp39 and Hsp90: actin' together in cell migration
por: Fotedar, Rati, et al.
Publicado: (2015)

Icariside II enhances cisplatin-induced apoptosis by promoting endoplasmic reticulum stress signalling in non-small cell lung cancer cells
por: Tang, Zhao, et al.
Publicado: (2022)

Slc25a39 and Slc25a40 Expression in Mice with Bile Duct Ligation or Lipopolysaccharide Treatment
por: Kawase, Atsushi, et al.
Publicado: (2022)

Upregulated SLC22A3 has a potential for improving survival of patients with head and neck squamous cell carcinoma receiving cisplatin treatment
por: Hsu, Cheng-Ming, et al.
Publicado: (2017)

Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer
por: Stathopoulos, G. P., et al.
Publicado: (2011)

SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma
por: Fan, Yongfei, et al.
Publicado: (2022)

Enhanced expression of cell-surface B-cell receptor-associated protein 31 contributes to poor survival of non-small cell lung carcinoma cells
por: Seo, Se-Ri, et al.
Publicado: (2017)

Decreased expression of SLC 39A14 is associated with tumor aggressiveness and biochemical recurrence of human prostate cancer
por: Xu, Xiao-Ming, et al.
Publicado: (2016)

Co-expression analysis revealed PTCH1-3'UTR promoted cell migration and invasion by activating miR-101-3p/SLC39A6 axis in non-small cell lung cancer: implicating the novel function of PTCH1
por: Wan, Xuechao, et al.
Publicado: (2017)

Recent Advances in the Role of SLC39A/ZIP Zinc Transporters In Vivo
por: Takagishi, Teruhisa, et al.
Publicado: (2017)

The Role of the Slc39a Family of Zinc Transporters in Zinc Homeostasis in Skin
por: Bin, Bum-Ho, et al.
Publicado: (2018)

The Zinc Transporter, Slc39a7 (Zip7) Is Implicated in Glycaemic Control in Skeletal Muscle Cells
por: Myers, Stephen A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_a6873v4ooqsvnf86mvan6m95eh